Literature DB >> 30152500

Porphyrinoid biohybrid materials as an emerging toolbox for biomedical light management.

Verónica Almeida-Marrero1, Eveline van de Winckel1, Eduardo Anaya-Plaza1, Tomás Torres2, Andrés de la Escosura3.   

Abstract

The development of photoactive and biocompatible nanomaterials is a current major challenge of materials science and nanotechnology, as they will contribute to promoting current and future biomedical applications. A growing strategy in this direction consists of using biologically inspired hybrid materials to maintain or even enhance the optical properties of chromophores and fluorophores in biological media. Within this area, porphyrinoids constitute the most important family of organic photosensitizers. The following extensive review will cover their incorporation into different kinds of photosensitizing biohybrid materials, as a fundamental research effort toward the management of light for biomedical use, including technologies such as photochemical internalization (PCI), photoimmunotherapy (PIT), and theranostic combinations of fluorescence imaging and photodynamic therapy (PDT) or photodynamic inactivation (PDI) of microorganisms.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30152500     DOI: 10.1039/c7cs00554g

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN: 0306-0012            Impact factor:   54.564


  21 in total

1.  Porphyrinoid Drug Conjugates.

Authors:  Jonathan F Arambula; Jonathan L Sessler
Journal:  Chem       Date:  2020-07-09       Impact factor: 22.804

2.  Intratumoral Photosensitizer Delivery and Photodynamic Therapy.

Authors:  Chen-Hua Ma; Jeffrey Yang; Jenna L Mueller; Huang-Chiao Huang
Journal:  Nano Life       Date:  2021-06-09

3.  Controlled assembly of a bicyclic porphyrinoid and its 3-dimensional boron difluoride arrays.

Authors:  Weinan Zhou; Tridib Sarma; Liu Yang; Chuanhu Lei; Jonathan L Sessler
Journal:  Chem Sci       Date:  2022-05-26       Impact factor: 9.969

4.  Peripherally Crowded Cationic Phthalocyanines as Efficient Photosensitizers for Photodynamic Therapy.

Authors:  Marie Halaskova; Asma Rahali; Verónica Almeida-Marrero; Miloslav Machacek; Radim Kucera; Bassem Jamoussi; Tomás Torres; Veronika Novakova; Andrés de la Escosura; Petr Zimcik
Journal:  ACS Med Chem Lett       Date:  2021-03-01       Impact factor: 4.345

5.  Bioorthogonal Turn-On BODIPY-Peptide Photosensitizers for Tailored Photodynamic Therapy.

Authors:  Greta Linden; Olalla Vázquez
Journal:  Chemistry       Date:  2020-07-23       Impact factor: 5.236

Review 6.  Azides and Porphyrinoids: Synthetic Approaches and Applications. Part 2-Azides, Phthalocyanines, Subphthalocyanines and Porphyrazines.

Authors:  Ana R L Araújo; Augusto C Tomé; Carla I M Santos; Maria A F Faustino; Maria G P M S Neves; Mário M Q Simões; Nuno M M Moura; Sultan T Abu-Orabi; José A S Cavaleiro
Journal:  Molecules       Date:  2020-04-10       Impact factor: 4.411

7.  Systematic Evaluation of Light-Activatable Biohybrids for Anti-Glioma Photodynamic Therapy.

Authors:  Collin T Inglut; Yan Baglo; Barry J Liang; Yahya Cheema; Jillian Stabile; Graeme F Woodworth; Huang-Chiao Huang
Journal:  J Clin Med       Date:  2019-08-21       Impact factor: 4.241

8.  Annulative π-extension of BODIPYs made easy via gold(i)-catalyzed cycloisomerization.

Authors:  Jorge Labella; Gonzalo Durán-Sampedro; M Victoria Martínez-Díaz; Tomás Torres
Journal:  Chem Sci       Date:  2020-06-12       Impact factor: 9.825

9.  Selective Photokilling of Human Pancreatic Cancer Cells Using Cetuximab-Targeted Mesoporous Silica Nanoparticles for Delivery of Zinc Phthalocyanine.

Authors:  Özge Er; Suleyman Gokhan Colak; Kasim Ocakoglu; Mine Ince; Roger Bresolí-Obach; Margarita Mora; Maria Lluïsa Sagristá; Fatma Yurt; Santi Nonell
Journal:  Molecules       Date:  2018-10-24       Impact factor: 4.411

10.  Development of albumin macroinitiator for polymers to use in DNA origami coating

Authors:  Aykut Bilir; Ezgi Emül; Necdet Sağlam
Journal:  Turk J Med Sci       Date:  2020-08-26       Impact factor: 0.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.